Top pharmaceutical companies' SG&A to revenue rate 2022
With some 52 percent, AstraZeneca had the highest SG&A-to-revenue rates among top pharmaceutical companies in 2022. Growth of selling, general, and administrative expenses should not exceed sales growth because it would cut a company's profitability. This statistic shows the selling, general, and administrative expenses to revenue rate of global top pharmaceutical companies in 2022.